Tytti Sarkeala

Summary

Affiliation: Finnish Cancer Registry
Country: Finland

Publications

  1. ncbi Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000
    T Sarkeala
    Finnish Cancer Registry, Liisankatu 21 B, Helsinki 00170
    Eur J Cancer 40:2116-25. 2004
  2. ncbi Validity of process indicators of screening for breast cancer to predict mortality reduction
    T Sarkeala
    Finnish Cancer Registry, Liisankatu 21 B, FIN 00170 Helsinki, Finland
    J Med Screen 12:33-7. 2005
  3. ncbi Episode sensitivity in association with process indicators in the Finnish breast cancer screening program
    Tytti Sarkeala
    Finnish Cancer Registry, Helsinki, Finland
    Int J Cancer 118:174-9. 2006
  4. ncbi Organised mammography screening reduces breast cancer mortality: a cohort study from Finland
    Tytti Sarkeala
    Finnish Cancer Registry, Helsinki, Finland
    Int J Cancer 122:614-9. 2008
  5. ncbi Breast cancer mortality with varying invitational policies in organised mammography
    T Sarkeala
    Finnish Cancer Registry, Helsinki, Finland
    Br J Cancer 98:641-5. 2008
  6. ncbi Impacts of the Finnish service screening programme on breast cancer rates
    Ahti Anttila
    Mass Screening Registry, Finnish Cancer Registry, Helsinki, Finland
    BMC Public Health 8:38. 2008
  7. ncbi Effects of different phases of an invitational screening program on breast cancer incidence
    Johanna Seppänen
    Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland
    Int J Cancer 119:920-4. 2006

Detail Information

Publications7

  1. ncbi Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000
    T Sarkeala
    Finnish Cancer Registry, Liisankatu 21 B, Helsinki 00170
    Eur J Cancer 40:2116-25. 2004
    ..However, the variation in PPVs was wide, as has been seen for other European mammography programmes, indicating meaningful differences in diagnostic criteria and potential adverse effects...
  2. ncbi Validity of process indicators of screening for breast cancer to predict mortality reduction
    T Sarkeala
    Finnish Cancer Registry, Liisankatu 21 B, FIN 00170 Helsinki, Finland
    J Med Screen 12:33-7. 2005
    ..The specific criteria of the European Community on stage distribution, rates of screen-detected cancers by stage and detection rate to background incidence may need reconsideration...
  3. ncbi Episode sensitivity in association with process indicators in the Finnish breast cancer screening program
    Tytti Sarkeala
    Finnish Cancer Registry, Helsinki, Finland
    Int J Cancer 118:174-9. 2006
    ..The sensitivity estimates were comparable with those from other European service screening programs. The variability in the episode sensitivity suggests potential for variations in the future screening outcome...
  4. ncbi Organised mammography screening reduces breast cancer mortality: a cohort study from Finland
    Tytti Sarkeala
    Finnish Cancer Registry, Helsinki, Finland
    Int J Cancer 122:614-9. 2008
    ..The relationship between the estimates of process and outcome of mammography is not yet straightforward: effectiveness and efficacy remain the best estimates for evaluating the success of mammography screening...
  5. ncbi Breast cancer mortality with varying invitational policies in organised mammography
    T Sarkeala
    Finnish Cancer Registry, Helsinki, Finland
    Br J Cancer 98:641-5. 2008
    ..The study confirms a reduction by screening of breast cancer mortality in Finland. Uniform extension of invitations to 60-69 years of age would increase the number of prevented breast cancer deaths among the elderly...
  6. ncbi Impacts of the Finnish service screening programme on breast cancer rates
    Ahti Anttila
    Mass Screening Registry, Finnish Cancer Registry, Helsinki, Finland
    BMC Public Health 8:38. 2008
    ..The programme has been historically targeted to a rather narrow age band, mainly women of ages 50-59 years...
  7. ncbi Effects of different phases of an invitational screening program on breast cancer incidence
    Johanna Seppänen
    Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland
    Int J Cancer 119:920-4. 2006
    ..2% if the program was continued up to age 59, and 28.0% if it continued up to age 69. Corresponding figures for nonlocalized cancers were decreases of 19.8% and 20.9%, respectively...